Royalty Pharma plc (RPRX) Insider Trading

Over the last 3 months, RPRX insiders made 0 open-market buys and 10 sales, a net sale of -$10.1M (SEC Form 4). Over the last 6 months, 494 institutions increased and 319 reduced their position (13F).

Insider Activity

Sentiment
0/100
Buys (3m)
0
Sells (3m)
10
Net (3m)
-$10.1M
Insider trades by month Buys Sells
Dec
Jan
Feb
Mar
Apr
May
Context3-month price +15.9%Institutions accumulating (13F)
DateInsiderTypeSharesPrice
May 28, 2026Coyne Terrance P.officer: EVP & CFOSell64,399$53.98
May 21, 2026Urist Marshallofficer: EVP, Research & InvestmentsSell13,684$52.75
May 15, 2026Norden GregorydirectorSell3,045$53.00
May 15, 2026Urist Marshallofficer: EVP, Research & InvestmentsSell13,684$53.06
May 8, 2026Hite Christopherofficer: EVP & Vice ChairmanGrant24,263
May 8, 2026Coyne Terrance P.officer: EVP & CFOGrant24,263
May 8, 2026Urist Marshallofficer: EVP, Research & InvestmentsGrant18,197
May 8, 2026Legorreta Pablo G.director, officer: CEO, Chairman of the BoardGrant143,821
Apr 30, 2026Coyne Terrance P.officer: EVP & CFOSell32,916$49.78
Apr 30, 2026Coyne Terrance P.officer: EVP & CFOSell1,875$49.78
Apr 2, 2026Coyne Terrance P.officer: EVP & CFOSell1,875$48.33
Apr 2, 2026Coyne Terrance P.officer: EVP & CFOSell32,916$48.33
Mar 31, 2026Bassler Bonnie LdirectorGrant815$45.98
Mar 25, 2026Coyne Terrance P.officer: EVP & CFOSell1,875$45.53
Mar 25, 2026Coyne Terrance P.officer: EVP & CFOSell32,916$45.53
Mar 4, 2026Coyne Terrance P.officer: EVP & CFOSell22,487$46.67
Mar 4, 2026Coyne Terrance P.officer: EVP & CFOSell583$47.01
Mar 4, 2026Coyne Terrance P.officer: EVP & CFOSell10,429$47.01
Mar 4, 2026Coyne Terrance P.officer: EVP & CFOSell1,292$46.67
Feb 25, 2026Coyne Terrance P.officer: EVP & CFOSell32,916$45.32
Feb 25, 2026Coyne Terrance P.officer: EVP & CFOSell1,875$45.32
Feb 13, 2026Hite Christopherofficer: EVP & Vice ChairmanGrant26,626
Feb 13, 2026Coyne Terrance P.officer: EVP & CFOGrant26,626
Feb 13, 2026Legorreta Pablo G.director, officer: CEO, Chairman of the BoardGrant157,828
Feb 13, 2026Urist Marshallofficer: EVP, Research & InvestmentsGrant19,970
Feb 4, 2026Coyne Terrance P.officer: EVP & CFOSell19,076$43.29
Feb 4, 2026Coyne Terrance P.officer: EVP & CFOSell108,759$42.84
Feb 4, 2026Coyne Terrance P.officer: EVP & CFOSell1,087$43.29
Feb 4, 2026Coyne Terrance P.officer: EVP & CFOSell5,843$42.08
Feb 4, 2026Coyne Terrance P.officer: EVP & CFOSell6,195$42.84

Source: RPRX SEC Form 4 filings, latest May 28, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their RPRX positions over the last 6 months (SEC Form 13F).

Increased
494
New positions
197
Reduced
319
Sold out
110
Largest moves
InstitutionActionSharesFiled
MORGAN STANLEYIncreased55.3MFeb 13, 2026
MORGAN STANLEYReduced43.6MMay 15, 2026
CAPITAL INTERNATIONAL INVESTORSIncreased35.0MMay 13, 2026
CAPITAL INTERNATIONAL INVESTORSIncreased31.1MFeb 11, 2026
FMR LLCReduced26.3MFeb 17, 2026
BLACKROCK, INC.Reduced26.2MFeb 12, 2026
BLACKROCK, INC.Reduced25.9MMay 13, 2026
FMR LLCReduced25.2MMay 15, 2026
BAILLIE GIFFORD & COReduced17.0MJan 23, 2026
BAILLIE GIFFORD & COReduced16.2MMay 8, 2026
SWEDBANK ABReduced11.9MFeb 9, 2026
ADAGE CAPITAL PARTNERS GP, L.L.C.Reduced11.7MFeb 17, 2026
SWEDBANK ABReduced11.6MApr 29, 2026
STATE STREET CORPIncreased11.0MMay 15, 2026
STATE STREET CORPIncreased10.6MFeb 13, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.